WHO warns drug-resistant TB spreading in Europe at 'alarming' rate, releases plan to fight disease

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports. "The WHO said that if the plan is fully implemented -- at an estimated cost of $5 billion -- 127,000 people will be successfully treated for drug-resistant TB and 120,000 deaths will be averted by 2015," according to the news agency (Kelland, 9/13).

"Eastern Europe has the highest level of infection, while in Western Europe, London has the highest TB rate of any capital city. The WHO estimates there are 81,000 cases of drug-resistant TB a year in Europe, although many countries are failing to diagnose it," BBC News writes (Dreaper, 9/13). "WHO says that in Western Europe treatment fails in 23 percent of patients, 26 percent are lost to follow-up, 19 percent die, and only 32 percent are successfully treated," according to BMJ (Mozynski, 9/14). "Rising immigration from infected areas has contributed to the rise of TB in Europe, but the WHO warned against complacency among the native populations," Agence France-Presse notes (9/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Toddlers exposed to the COVID pandemic show fewer behavioral problems